$DWTX Dogwood Therapeutics Secures Exclusive Worldwide, Royalty Free License to Develop and Commercialize SP16 as a Treatment for Cancer Related Pain in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients.
Add $TEM to the list of stocks that consistently act like $RDDT, $ALAB, $NVDA, $PLTR and others. Don’t get me wrong I’m long each of these… made great money on them… and still despise them.
$OPEN While many people wants a crash on this name, from a technical standpoint the stock still in a bullish consoldation within an ascending channel. Never forget, as long as the trend is strong, like this case, t
HERE'S WHAT ANALYSTS HAVE TO SAY ON $GOOGL FOLLOWING DOJ RULING:
Piper Sandler (OW; PT $220) – Thomas Champion
"GOOGL shares are +7% AH... tone was highly measured, seemingly rejecting Plaintiff structural proposals including i) Chrome & Android divestiture, and ii) the banning of payments to distribution partners. Google will likely be required to share some data... But... this is a positive outcome... avoiding a structural remedy... removing the potential for Chrome/Android divestiture."
Bernstein (MP; PT $210) – Mark Shmulik
"Judge Mehta delivered his much-anticipated... 230-page Memorandum Opinion driving Google’s stock up +7%... The killer one-two punch of selling off Chrome AND being unable to pay for distribution never materialized... Google’s near-term risk is probably worse today than yesterday... but easier to own today than yesterday. Fears are sometimes worse than the monsters themselves."
Rosenblatt (Neutral; PT $224) – Barton Crockett
"Ruling bolsters long-term competitive risks... but takes the near-term potential of breakup or disruption to the Apple distribution deal off the table... We factor less risk into a higher multiple assumption (13x EV/EBITDA now, 11x before)... We retain NEUTRAL... long-term concerns about search will constrain the multiple."
Evercore ISI (OP; PT $240) – Mark Mahaney
"Court declined structural remedies and a broad payment ban... adopted tailored data-sharing and syndication obligations... decree runs six years... explicitly brings GenAI search access points within scope. Bottom line, we view these results as a 'best case scenario'... reiterate GOOGL as our top pick."
Wedbush (OP; PT $245) – Scott Devitt
"Compelling case for multiple expansion... decision removes lingering risks... concerns around genAI fading... Cloud growth accelerating. Focus shifts towards positioning relative to megacap peers... increasingly constructive in the longer-term durability of Search."
Needham (Buy; PT $260) – Laura Martin
"Preliminary remedies were far better... We believe this decision will save GOOGL $5B–$10B/year in lower rev share fees paid to AAPL... will lower the risk that structural remedies are applied in the next DOJ trial... We raise PT to $260, up 18%."
BofA Securities (Buy; PT $252) – Justin Post
"Court ruling a win: Chrome divestiture avoided, TAC payments remain, and data-sharing limited... Syndication obligations minor. Maintain Buy."
Goldman Sachs (Buy; PT $234) – Eric Sheridan
"Remedies less severe than feared... decision may act as 'relief' on the multiple overhang... remain constructive on Alphabet’s long-term strategic positioning... leading collection of AI/machine learning-driven businesses."
Barclays (OW; PT $250) – Ross Sandler
"After 5+ years of courtroom drama, Google is only facing a few minor flesh wounds... denial of Chrome divestiture and elimination of TAC payments ensures most search share remains intact... Battleground shifts back to AI... Gemini distribution a big win vs. ChatGPT."
Citizens JMP (MO; PT $250) – Andrew Boone
"Google can continue to make distribution payments and control Android and Chrome... ChatGPT still too small to materially impact results... AI benefits of improved search relevancy overwhelm share loss near term... Overhang removed, AI leadership intact."
KeyBanc (OW; PT $265) – Justin Patterson
"DOJ ruling better than feared, clearing event for shares... With AI tailwinds and Cloud growth, investors will return to look at asset value... assets trading at ~15x 2027E P/E... Raise PT to $265."